SB290157 trifluacetate 是一种有效的选择性 C3a 受体拮抗剂（IC50 为 200 nM）。 SB 290157 是 125I-C3a 放射性配体的竞争性拮抗剂，与表达人 C3aR（RBL-C3aR，IC50 为 200 nM）的大鼠嗜碱性白血病-2H3 细胞结合。

(+)-Balanophonin exhibits marginal inhibition on the proliferation of OPM2 and RPMI-8226 cells.

Potassium trimethylsilanolate is a catalyst. Potassium trimethylsilanolate promotes the Suzuki-Miyaura reaction by (TMSOK) proceeds through the boronate pathway.